<DOC>
	<DOCNO>NCT01136824</DOCNO>
	<brief_summary>Assessments ( survey data ) study design sample symptom burden patient undergo adjuvant neoadjuvant chemotherapy hospital . There change treatment plan patient .</brief_summary>
	<brief_title>Chemotherapy-induced Symptoms Sarcoma Patients Impact Tumor Burden</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<criteria>Patients receive doxorubicin plus ifosfamide ( AI ) There exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Sarcoma</keyword>
	<keyword>questionnaire</keyword>
	<keyword>doxorubicin plus ifosfamide ( AI )</keyword>
</DOC>